Reviews Emtriva


No reviews yet.

Emtriva Drug Description
EMTRIVA®
(emtricitabine) Capsule
EMTRIVA
(emtricitabine) Oral Solution

WARNINGS: LACTIC ACIDOSIS/SEVERE HEPATOMEGALY WITH STEATOSIS
and POST TREATMENT EXACERBATION OF HEPATITIS B
Lactic acidosis and severe hepatomegaly with steatosis, including fatal
cases, have been reported with the use of nucleoside analogs alone or in combination
with other antiretrovirals [See WARNINGS and PRECAUTIONS].
EMTRIVA is not approved for the treatment of chronic hepatitis B virus (HBV) infection and the safety and efficacy of EMTRIVA have not been established
in patients coinfected with HBV or HIV-1. Severe acute exacerbations of hepatitis
B have been reported in patients who have discontinued EMTRIVA. Hepatic function
should be monitored closely with both clinical and laboratory follow-up for
at least several months in patients who are coinfected with HIV-1 and HBV
and discontinue EMTRIVA. If appropriate, initiation of anti-hepatits B therapy
may be warranted [See WARNINGS and PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of emtricitabine (Emtriva)?

Stop using emtricitabine and get emergency medical help if you have any of these signs of an allergic reaction : hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Emtricitabine may cause lactic acidosis (a build-up of lactic acid in the body, which can be fatal). Lactic acidosis can start slowly and get worse over time. Get emergency medical help if you have even mild symptoms of lactic acidosis, such as:

muscle pain or weakness;
numb or cold feeling...
Read All Potential Side Effects for Emtriva »




EMTRIVA is the brand name of emtricitabine, a synthetic nucleoside analog with
activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.
The chemical name of emtricitabine is 5-fluoro-1-(2R,5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.
Emtricitabine is the (-) enantiomer of a thio analog of cytidine, which differs
from other cytidine analogs in that it has a fluorine in the 5-position.
It has a molecular formula of C8H10FN3O3S
and a molecular weight of 247.24. It has the following structural formula:








Emtricitabine is a white to off-white powder with a solubility of approximately
112 mg/mL in water at 25 ° C. The log P for emtricitabine is -0.43 and the pKa
is 2.65.
EMTRIVA is available as capsules or as an oral solution.
EMTRIVA capsules are for oral administration. Each capsule contains 200 mg
of emtricitabine and the inactive ingredients, crospovidone, magnesium stearate,
microcrystalline cellulose, and povidone.
EMTRIVA oral solution is for oral administration. One milliliter (1 mL) of
EMTRIVA oral solution contains 10 mg of emtricitabine in an aqueous solution
with the following inactive ingredients: cotton candy flavor, FD&C yellow
No. 6, edetate disodium, methylparaben, and propylparaben (added as preservatives),
sodium phosphate (monobasic), propylene glycol, water, and xylitol (added as
a sweetener). Sodium hydroxide and hydrochloric acid may be used to adjust pH.Last reviewed on RxList: 7/7/2008




Emtriva Drug Description
EMTRIVA®
(emtricitabine) Capsule
EMTRIVA
(emtricitabine) Oral Solution

WARNINGS: LACTIC ACIDOSIS/SEVERE HEPATOMEGALY WITH STEATOSIS
and POST TREATMENT EXACERBATION OF HEPATITIS B
Lactic acidosis and severe hepatomegaly with steatosis, including fatal
cases, have been reported with the use of nucleoside analogs alone or in combination
with other antiretrovirals [See WARNINGS and PRECAUTIONS].
EMTRIVA is not approved for the treatment of chronic hepatitis B virus (HBV) infection and the safety and efficacy of EMTRIVA have not been established
in patients coinfected with HBV or HIV-1. Severe acute exacerbations of hepatitis
B have been reported in patients who have discontinued EMTRIVA. Hepatic function
should be monitored closely with both clinical and laboratory follow-up for
at least several months in patients who are coinfected with HIV-1 and HBV
and discontinue EMTRIVA. If appropriate, initiation of anti-hepatits B therapy
may be warranted [See WARNINGS and PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of emtricitabine (Emtriva)?

Stop using emtricitabine and get emergency medical help if you have any of these signs of an allergic reaction : hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Emtricitabine may cause lactic acidosis (a build-up of lactic acid in the body, which can be fatal). Lactic acidosis can start slowly and get worse over time. Get emergency medical help if you have even mild symptoms of lactic acidosis, such as:

muscle pain or weakness;
numb or cold feeling...
Read All Potential Side Effects for Emtriva »




EMTRIVA is the brand name of emtricitabine, a synthetic nucleoside analog with
activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.
The chemical name of emtricitabine is 5-fluoro-1-(2R,5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.
Emtricitabine is the (-) enantiomer of a thio analog of cytidine, which differs
from other cytidine analogs in that it has a fluorine in the 5-position.
It has a molecular formula of C8H10FN3O3S
and a molecular weight of 247.24. It has the following structural formula:








Emtricitabine is a white to off-white powder with a solubility of approximately
112 mg/mL in water at 25 ° C. The log P for emtricitabine is -0.43 and the pKa
is 2.65.
EMTRIVA is available as capsules or as an oral solution.
EMTRIVA capsules are for oral administration. Each capsule contains 200 mg
of emtricitabine and the inactive ingredients, crospovidone, magnesium stearate,
microcrystalline cellulose, and povidone.
EMTRIVA oral solution is for oral administration. One milliliter (1 mL) of
EMTRIVA oral solution contains 10 mg of emtricitabine in an aqueous solution
with the following inactive ingredients: cotton candy flavor, FD&C yellow
No. 6, edetate disodium, methylparaben, and propylparaben (added as preservatives),
sodium phosphate (monobasic), propylene glycol, water, and xylitol (added as
a sweetener). Sodium hydroxide and hydrochloric acid may be used to adjust pH.Last reviewed on RxList: 7/7/2008




Emtriva Drug Description
EMTRIVA®
(emtricitabine) Capsule
EMTRIVA
(emtricitabine) Oral Solution

WARNINGS: LACTIC ACIDOSIS/SEVERE HEPATOMEGALY WITH STEATOSIS
and POST TREATMENT EXACERBATION OF HEPATITIS B
Lactic acidosis and severe hepatomegaly with steatosis, including fatal
cases, have been reported with the use of nucleoside analogs alone or in combination
with other antiretrovirals [See WARNINGS and PRECAUTIONS].
EMTRIVA is not approved for the treatment of chronic hepatitis B virus (HBV) infection and the safety and efficacy of EMTRIVA have not been established
in patients coinfected with HBV or HIV-1. Severe acute exacerbations of hepatitis
B have been reported in patients who have discontinued EMTRIVA. Hepatic function
should be monitored closely with both clinical and laboratory follow-up for
at least several months in patients who are coinfected with HIV-1 and HBV
and discontinue EMTRIVA. If appropriate, initiation of anti-hepatits B therapy
may be warranted [See WARNINGS and PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of emtricitabine (Emtriva)?

Stop using emtricitabine and get emergency medical help if you have any of these signs of an allergic reaction : hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Emtricitabine may cause lactic acidosis (a build-up of lactic acid in the body, which can be fatal). Lactic acidosis can start slowly and get worse over time. Get emergency medical help if you have even mild symptoms of lactic acidosis, such as:

muscle pain or weakness;
numb or cold feeling...
Read All Potential Side Effects for Emtriva »




EMTRIVA is the brand name of emtricitabine, a synthetic nucleoside analog with
activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.
The chemical name of emtricitabine is 5-fluoro-1-(2R,5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.
Emtricitabine is the (-) enantiomer of a thio analog of cytidine, which differs
from other cytidine analogs in that it has a fluorine in the 5-position.
It has a molecular formula of C8H10FN3O3S
and a molecular weight of 247.24. It has the following structural formula:








Emtricitabine is a white to off-white powder with a solubility of approximately
112 mg/mL in water at 25 ° C. The log P for emtricitabine is -0.43 and the pKa
is 2.65.
EMTRIVA is available as capsules or as an oral solution.
EMTRIVA capsules are for oral administration. Each capsule contains 200 mg
of emtricitabine and the inactive ingredients, crospovidone, magnesium stearate,
microcrystalline cellulose, and povidone.
EMTRIVA oral solution is for oral administration. One milliliter (1 mL) of
EMTRIVA oral solution contains 10 mg of emtricitabine in an aqueous solution
with the following inactive ingredients: cotton candy flavor, FD&C yellow
No. 6, edetate disodium, methylparaben, and propylparaben (added as preservatives),
sodium phosphate (monobasic), propylene glycol, water, and xylitol (added as
a sweetener). Sodium hydroxide and hydrochloric acid may be used to adjust pH.Last reviewed on RxList: 7/7/2008




Emtriva Drug Description
EMTRIVA®
(emtricitabine) Capsule
EMTRIVA
(emtricitabine) Oral Solution

WARNINGS: LACTIC ACIDOSIS/SEVERE HEPATOMEGALY WITH STEATOSIS
and POST TREATMENT EXACERBATION OF HEPATITIS B
Lactic acidosis and severe hepatomegaly with steatosis, including fatal
cases, have been reported with the use of nucleoside analogs alone or in combination
with other antiretrovirals [See WARNINGS and PRECAUTIONS].
EMTRIVA is not approved for the treatment of chronic hepatitis B virus (HBV) infection and the safety and efficacy of EMTRIVA have not been established
in patients coinfected with HBV or HIV-1. Severe acute exacerbations of hepatitis
B have been reported in patients who have discontinued EMTRIVA. Hepatic function
should be monitored closely with both clinical and laboratory follow-up for
at least several months in patients who are coinfected with HIV-1 and HBV
and discontinue EMTRIVA. If appropriate, initiation of anti-hepatits B therapy
may be warranted [See WARNINGS and PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of emtricitabine (Emtriva)?

Stop using emtricitabine and get emergency medical help if you have any of these signs of an allergic reaction : hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Emtricitabine may cause lactic acidosis (a build-up of lactic acid in the body, which can be fatal). Lactic acidosis can start slowly and get worse over time. Get emergency medical help if you have even mild symptoms of lactic acidosis, such as:

muscle pain or weakness;
numb or cold feeling...
Read All Potential Side Effects for Emtriva »




EMTRIVA is the brand name of emtricitabine, a synthetic nucleoside analog with
activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.
The chemical name of emtricitabine is 5-fluoro-1-(2R,5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.
Emtricitabine is the (-) enantiomer of a thio analog of cytidine, which differs
from other cytidine analogs in that it has a fluorine in the 5-position.
It has a molecular formula of C8H10FN3O3S
and a molecular weight of 247.24. It has the following structural formula:








Emtricitabine is a white to off-white powder with a solubility of approximately
112 mg/mL in water at 25 ° C. The log P for emtricitabine is -0.43 and the pKa
is 2.65.
EMTRIVA is available as capsules or as an oral solution.
EMTRIVA capsules are for oral administration. Each capsule contains 200 mg
of emtricitabine and the inactive ingredients, crospovidone, magnesium stearate,
microcrystalline cellulose, and povidone.
EMTRIVA oral solution is for oral administration. One milliliter (1 mL) of
EMTRIVA oral solution contains 10 mg of emtricitabine in an aqueous solution
with the following inactive ingredients: cotton candy flavor, FD&C yellow
No. 6, edetate disodium, methylparaben, and propylparaben (added as preservatives),
sodium phosphate (monobasic), propylene glycol, water, and xylitol (added as
a sweetener). Sodium hydroxide and hydrochloric acid may be used to adjust pH.Last reviewed on RxList: 7/7/2008




Emtriva Drug Description
EMTRIVA®
(emtricitabine) Capsule
EMTRIVA
(emtricitabine) Oral Solution

WARNINGS: LACTIC ACIDOSIS/SEVERE HEPATOMEGALY WITH STEATOSIS
and POST TREATMENT EXACERBATION OF HEPATITIS B
Lactic acidosis and severe hepatomegaly with steatosis, including fatal
cases, have been reported with the use of nucleoside analogs alone or in combination
with other antiretrovirals [See WARNINGS and PRECAUTIONS].
EMTRIVA is not approved for the treatment of chronic hepatitis B virus (HBV) infection and the safety and efficacy of EMTRIVA have not been established
in patients coinfected with HBV or HIV-1. Severe acute exacerbations of hepatitis
B have been reported in patients who have discontinued EMTRIVA. Hepatic function
should be monitored closely with both clinical and laboratory follow-up for
at least several months in patients who are coinfected with HIV-1 and HBV
and discontinue EMTRIVA. If appropriate, initiation of anti-hepatits B therapy
may be warranted [See WARNINGS and PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of emtricitabine (Emtriva)?

Stop using emtricitabine and get emergency medical help if you have any of these signs of an allergic reaction : hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Emtricitabine may cause lactic acidosis (a build-up of lactic acid in the body, which can be fatal). Lactic acidosis can start slowly and get worse over time. Get emergency medical help if you have even mild symptoms of lactic acidosis, such as:

muscle pain or weakness;
numb or cold feeling...
Read All Potential Side Effects for Emtriva »




EMTRIVA is the brand name of emtricitabine, a synthetic nucleoside analog with
activity against human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.
The chemical name of emtricitabine is 5-fluoro-1-(2R,5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.
Emtricitabine is the (-) enantiomer of a thio analog of cytidine, which differs
from other cytidine analogs in that it has a fluorine in the 5-position.
It has a molecular formula of C8H10FN3O3S
and a molecular weight of 247.24. It has the following structural formula:








Emtricitabine is a white to off-white powder with a solubility of approximately
112 mg/mL in water at 25 ° C. The log P for emtricitabine is -0.43 and the pKa
is 2.65.
EMTRIVA is available as capsules or as an oral solution.
EMTRIVA capsules are for oral administration. Each capsule contains 200 mg
of emtricitabine and the inactive ingredients, crospovidone, magnesium stearate,
microcrystalline cellulose, and povidone.
EMTRIVA oral solution is for oral administration. One milliliter (1 mL) of
EMTRIVA oral solution contains 10 mg of emtricitabine in an aqueous solution
with the following inactive ingredients: cotton candy flavor, FD&C yellow
No. 6, edetate disodium, methylparaben, and propylparaben (added as preservatives),
sodium phosphate (monobasic), propylene glycol, water, and xylitol (added as
a sweetener). Sodium hydroxide and hydrochloric acid may be used to adjust pH.Last reviewed on RxList: 7/7/2008





Other reviews about Emtriva on wordpress

happy pills indeed :
  by Christopher
Bristol-Myers Squibb and Gilead Sciences today announced that a once-a-day pill could be ready soon. They have been working to combine the most popular AIDS (or Aids, if […]


TRUVADA - HIV AIDS Treatment Drug
  by truvada
What is Truvada? -Truvada is an antiviral medication. Truvada inhibits the reproduction of HIV in the body. -Truvada is used to treat the human immunodeficiency virus (HIV), which causes […]


NDA applications continue to decline
  by silico
Between 1996 and 2006 the number of new drug applications (NDAs) approved by the US FDA declined by 10 percent, dropping from 289 to 259. Silico Research's analysis […]


Are universities the nation's scientific powerhouse or little more than costly ivory towers?
  by silico
American universities are supposed to be becoming the nation's scientific powerhouse, turning innovative research into the applied science that will drive new products and wealth creation. Well that's […]


Nursing Schools In Northeast Ohio
  by twi321


ARTICLE: Costs of Common HIV Meds
  by ucanwalkonwater
  It's no secret, HIV medicines are very expensive. For most, insurances, drug assistance programs, or community resources pay most of the cost. But what about those who are […]


Gilead Sciences to Buy CV Therapeutics for $1.4 Billion
  by onetime123
Gilead Sciences has agreed to buy Palo Alto-based CV Therapeutics for $1.4 billion dollars. According to SF Gate, Gilead Sciences will pay $20 per share for CV Therapeutics, which […]


Gilead Sues Teva over HIV Drug
  by Dr Michael Factor
Gilead Sciences Inc. has announced that it will sue Teva Pharmaceuticals Industries Ltd. over the Israel drug manufacturer's plans to make a generic version of Atripla, for treating […]


Gilead HIV fighter fares well in study
  by conantadmin
Source:  San Francisco Business Times "An experimental four-in-one, once-a-day drug to treat HIV from Gilead Sciences Inc. was at least as effective as the company’s multibillion-dollar, three-in-one-pill in a […]



Other reviews about Emtriva on web:

Complete info about Emtriva (emtricitabine), a nucleoside analogue ... Emtriva belongs to a class of anti-HIV drugs called Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs). AIDSmeds.com - Emtriva


Learn about the prescription medication Emtriva (Emtricitabine), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Emtriva (Emtricitabine) Drug Information: Uses, Side Effects, Drug ...


© Gilead Sciences, Inc. All rights reserved. Gilead HIV Resource Library: Home


Prescribing information from Gilead Sciences. Emtriva


Emtriva (emtricitabine) is used to treat HIV, which causes the acquired immunodeficiency syndrome (AIDS). Includes Emtriva side effects, interactions and indications. Emtriva Information from Drugs.com


Accurate, FDA approved Emtriva information for healthcare professionals and patients - brought to you by Drugs.com. Emtriva Official FDA information, side effects and uses.


Emtricitabine (FTC), with trade name Emtriva (formerly Coviracil), is a nucleoside reverse transcriptase inhibitor (NRTI) for the treatment of HIV infection in adults and children. Emtricitabine - Wikipedia, the free encyclopedia


Up-to-date HIV and AIDS and Hepatitis treatment and care information Emtriva (emtricitabine; FTC)


Emtriva is an antiviral medicine used in combination with other antiviral medicines for the treatment of Human Immunodeficiency Virus (HIV) infection in patients over 3 months of ... Emtriva - drugstore.com. Low prices, side effects, interactions.


Emtriva is a prescription medicine used in the treatment of HIV and AIDS. This eMedTV article offers an overview of this medication, including information on how it works, possible ... Emtriva





Featured Reviews

Reviews Methyldopate Hcl

Methyldopate Hcl Drug Description Methyldopate Hcl (methyldopate hydrochloride) Injection, Solution DRUG DESCRIPTION Methyldopate HCl Injection, USP, is an antihypertensive agent for intravenous use. Sterile, nonpyrogenic. Methyldopate...
Read More  |  Review This
Reviews Bacteriostatic Water for Injection

Bacteriostatic Water Drug Description BACTERIOSTATIC WATER for Injection, USP Multiple-dose Plastic Vial WARNING NOT FOR USE IN NEONATES. DRUG DESCRIPTION The following preparation is designed solely for parenteral use only after...
Read More  |  Review This
Reviews Sporanox Oral Solution

Sporanox Oral Solution Drug Description SPORANOX® (itraconazole) Oral Solution Congestive Heart Failure: When itraconazole was administered intravenously to dogs and healthy human volunteers, negative inotropic effects were seen....
Read More  |  Review This
Reviews Orap

Orap Drug Description ORAP® (pimozide) Tablets DRUG DESCRIPTION What are the possible side effects of pimozide (Orap)? Call your doctor immediately if you experience uncontrollable movements of the mouth, tongue, cheeks, jaw,...
Read More  |  Review This
Reviews Oxistat

Oxistat Drug Description OXISTAT® (oxiconazole nitrate cream) Cream, 1%* OXISTAT® (oxiconazole nitrate lotion) Lotion, 1%* *Potency expressed as oxiconazole FOR TOPICAL DERMATOLOGIC USE ONLY- NOT FOR OPHTHALMIC OR INTRAVAGINAL...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....